Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Cancer Prevention and Research Institute of Texas

Investor type Government Office

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 38
Average round size
info
The average size of a deal this fund participated in
$8M
Portfolio companies 30
Rounds per year 2.53
Lead investments 12
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.21
Exits 12
Key employees Soon

Areas of investment

  • Biotechnology
  • Health Care
  • Medical
  • Pharmaceutical
  • Therapeutics
Summary

In 2007 was created Cancer Prevention and Research Institute of Texas, which is appeared as Corporate Investor. The fund was located in North America if to be more exact in United States. The main department of described Corporate Investor is located in the Austin.

The top activity for fund was in 2016. Despite it in 2019 the fund had an activity. The increased amount of exits for fund were in 2017. Considering the real fund results, this Corporate Investor is 36 percentage points more often commits exit comparing to other organizations. The usual things for fund are deals in the range of 5 - 10 millions dollars. The fund is generally included in 2-6 deals every year. This Cancer Prevention and Research Institute of Texas works on 10 percentage points less the average amount of lead investments comparing to the other organizations.

The typical case for the fund is to invest in rounds with 1-2 participants. Despite the Cancer Prevention and Research Institute of Texas, startups are often financed by Sante Ventures, Mercury Fund, UT Horizon Fund. The meaningful sponsors for the fund in investment in the same round are immatics biotechnologies, angelMD, Sante Ventures. In the next rounds fund is usually obtained by Texas Halo Fund, Sante Ventures, Salem Partners.

Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the most successful fund investment fields, there are Health Diagnostics, Pharmaceutical. Among the most popular portfolio startups of the fund, we may highlight AlloVir, Onconano Medicine, DNAtriX. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has no exact preference in some founders of portfolio startups. If startup sums 4 of the founder, the chance for it to be financed is low.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Cancer Prevention and Research Institute of Texas:
Typical Co-investors
Cancer Prevention and Research Institute of Texas is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Cancer Prevention and Research Institute of Texas:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Ace Capital Partners France, Ile-de-France, Paris
Capital Z Partners New York, New York, United States
Elemental Energy -
Granatus Ventures Armenia, Yerevan
incTANK Ventures Cambridge, Massachusetts, United States
Ivy Capital China, Shanghai
Myriad Genetics Salt Lake City, United States, Utah
Nordic Impact Norway, Oslo
Xintuo Information Technology China, Hangzhou, Zhejiang

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

ImmuneSensor Therapeutics

Biotechnology
Health Care
Medical
Pharmaceutical
$16M20 Sep 2022 Dallas, Texas, United States

Nucore Medical

Medical
Pharmaceutical
$3M22 Aug 2022 -

Emtora Biosciences

Biotechnology
Health Care
Life Science
Manufacturing
Pharmaceutical
$16M19 Aug 2022 San Antonio, Texas, United States

InformAI

Artificial Intelligence
Health Care
Image Recognition
Machine Learning
Medical
Software
$1M17 Aug 2022 Houston, Texas, United States

University of Texas Health Science Center at San Antonio

Education
Health Care
Medical
$10M17 Feb 2022 Texas, United States

Onconano Medicine

Alternative Medicine
Biotechnology
Health Care
Nanotechnology
$18M25 Oct 2021 Dallas, Texas, United States

Salarius Pharmaceuticals

Biotechnology
Pharmaceutical
$2M28 Sep 2021 Houston, Texas, United States

Dialectic Therapeutics

Biotechnology
Life Science
Pharmaceutical
$14M20 Aug 2021 Dallas, Texas, United States

Marker Therapeutics

Biotechnology
Therapeutics
$13M19 Aug 2021 Minneapolis, Minnesota, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Cancer Prevention and Research Institute of Texas?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: